Scherz-Shouval and colleagues characterize the dynamic changes in cancer-associated fibroblast subpopulations during breast cancer progression. They find that the ratio of S100A4+ and PDPN+ CAF subsets is associated with clinical outcome.
- Gil Friedman
- Oshrat Levi-Galibov
- Ruth Scherz-Shouval
